Blackstone and its BioMed Realty affiliate have paid $250M to acquire three Kendall Square life sciences buildings. The deal ...

Editas Medicine Inc.股价跌至52周新低，触及1.27美元，较52周高点11.58美元大幅下跌89%。这家生物科技公司目前市值仅为1.06亿美元，尽管其资产负债表健康，现金多于债务，但仍面临市场逆风。这一最新价格较之前的估值显著下降，反映出过去一年88%的急剧下跌。投资者对公司前景持谨慎态度，导致持续抛售，最终达到这一新低。根据 InvestingPro ...

Leerink Partners analyst Mani Foroohar maintained a Buy rating on Schrodinger (SDGR – Research Report) on December 18. The company’s shares ...

To develop RNA medicines targeting a proprietary bundle of tumor antigens, Epitopea is tapping nucleic acid delivery ...

Nearly all the patients with severe SCD treated with the gene-editing therapy reni-cel remained free of VOEs for up to two ...

Leerink Partners analyst Mani Foroohar maintained a Hold rating on Alnylam Pharma (ALNY – Research Report) yesterday. The company’s shares ...

Sanofi has filed a lawsuit against the Biden administration over payment terms in a federal drug discount program.

VersaBank Prices Public Offering of 5.66M Shares at Price of US$13.25 Per Share; Gross Proceeds From Offering Expected to Be Approximately US$75M; Net Proceeds to Be Used for General Banking Purposes, ...